[HTML][HTML] Aerosol delivery systems for treating obstructive airway diseases during the SARS-CoV-2 pandemic

F Lavorini, OS Usmani, R Dhand - Internal and Emergency Medicine, 2021 - Springer
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes
CoronaVirus Disease 2019 (COVID-19), has resulted in a worldwide pandemic and …

[HTML][HTML] Guidance on nebulization during the current COVID-19 pandemic

M Cazzola, J Ora, A Bianco, P Rogliani, MG Matera - Respiratory medicine, 2021 - Elsevier
Awareness of the risk of airborne transmission of SARS-CoV-2 makes patients hesitant
about using inhaled medications that are considered as a potential source of viral …

The use of nebulized pharmacotherapies during the COVID-19 pandemic

S Sethi, IZ Barjaktarevic… - Therapeutic Advances in …, 2020 - journals.sagepub.com
Coronavirus disease 2019 (COVID-19), caused by the highly contagious novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in a worldwide pandemic …

[HTML][HTML] Practical strategies for a safe and effective delivery of aerosolized medications to patients with COVID-19

A Ari - Respiratory Medicine, 2020 - Elsevier
The COVID-19, the disease caused by a novel coronavirus and named severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread rapidly across the globe. It …

[HTML][HTML] Nebulization: a potential source of SARS-CoV-2 transmission

G Reychler, L Vecellio, JC Dubus - Respiratory medicine and …, 2020 - ncbi.nlm.nih.gov
The risk of airborne transmission of SARS-CoV-2 by patients with Coronavirus disease 2019
(Covid-19) is unclear [1]. However, the Aerosoltherapy workgroup (GAT) of the Société de …

Evidence-based treatment during the SARS-CoV-2 pandemic: identifying the knowns and unknowns of nebulization

JA Woods - Journal of the American Pharmacists Association, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus
19 (COVID-19), has resulted in a worldwide pandemic and currently represents a major …

[HTML][HTML] Aerosol drug delivery to tracheotomized patients with COVID-19: pragmatic suggestions for clinicians

A Ari, JB Fink - Canadian Journal of Respiratory Therapy: CJRT …, 2021 - ncbi.nlm.nih.gov
Because of the wide and rapid spread of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), the number of hospitalized patients with coronavirus disease 2019 (COVID …

[HTML][HTML] Nebulized treatments and the possible risk of coronavirus transmission: where is the evidence?

DP Tashkin, IZ Barjaktarevic - Chronic Obstructive Pulmonary …, 2020 - ncbi.nlm.nih.gov
The worldwide outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has brought into focus the need for clear and accurate guidance on the use of aerosol …

[HTML][HTML] Promoting safe and effective use of aerosol devices in COVID-19: risks and suggestions for viral transmission

A Ari - Expert Opinion on Drug Delivery, 2020 - Taylor & Francis
While aerosol devices play a crucial role in the treatment of pulmonary diseases, aerosol
drug delivery is considered as a risk for viral transmission and cross-infection between …

Urgent appeal from international society for aerosols in medicine (ISAM) during COVID-19: clinical decision makers and governmental agencies should consider the …

JP Mitchell, A Berlinski, S Canisius… - Journal of aerosol …, 2020 - liebertpub.com
The present COVID-19 pandemic caused by the SARS-CoV-2 has resulted in massive
disruption to the normal operation of societies worldwide. There is currently the prospect of a …